Back to Search
GERSHON LOCKER, MD
MD
Medical Oncology Physician
NPI: 1134145469Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial.
PMID 17245540·Breast Cancer Res Treat·2007
8-other
The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
PMID 16875934·Cancer Genet Cytogenet·2006
8-other
Genetic factors and colorectal cancer in Ashkenazi Jews.
PMID 15516844·Fam Cancer·2004
4-observational
Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.
PMID 15305403·Cancer·2004
3-trial
Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysis.
PMID 18764830·Transpl Int·2008
5-case
Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma.
PMID 17661212·Cancer Invest·2007
3-trial
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial.
PMID 17622238·Br J Cancer·2007
4-observational
Prolonged lateral steep position impairs respiratory mechanics during continuous lateral rotation therapy in respiratory failure.
PMID 17252227·Intensive Care Med·2007
3-trial
[Management of capecitabine-induced hand-foot syndrome by local phytotherapy].
PMID 17704983·Wien Med Wochenschr·2007
4-observational
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer.
PMID 17028979·Breast Cancer Res Treat·2007
3-trial
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
PMID 16887480·Lancet Oncol·2006
4-observational
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.
PMID 16944295·Breast Cancer Res Treat·2006
4-observational
Airway management with endotracheal tube versus Combitube during parabolic flights.
PMID 17006067·Anesthesiology·2006
4-observational
Influence of inhaled nitric oxide on plasma nitrate concentrations in patients with adult respiratory distress syndrome and sepsis: results of a pilot study.
PMID 16731319·J Clin Anesth·2006
8-other
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
PMID 16563172·BMC Cancer·2006
3-trial
Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
PMID 16563704·Int J Antimicrob Agents·2006
8-other
Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
PMID 16635072·Vox Sang·2006
8-other
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
PMID 17060676·J Clin Oncol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2650 RIDGE AVE, DIV. OF HEMATOLOGY-ONCOLOGY
EVANSTON, IL 60201 - Phone
- (888) 909-5222
Quick Facts
- NPI
- 1134145469
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile